2m 2m 2m 2m 2m 2m 2m
Protagonist Ther (PTGX)
NASDAQ
$132.86-$2.00 (-1.48%)
Price as of Nov 12, 2026 10:02 AM EST- $8.8BMarket Cap
- 58.94%1-Year Change
- BiotechnologyIndustry
Protagonist Ther (PTGX)
$132.86-$2.00 (-1.48%)
PTGX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $134.86 | ||
Change | -$1.40 (-1.03%) | ||
Open | $136.51 | ||
High | $136.98 | ||
Low | $132.03 | ||
Previous Close | $136.26 | ||
Volume | 332,592 | ||
30-Day Average Volume | 654,759 | ||
1-Week Change | -5.94% | ||
1-Month Change | -6.17% | ||
1-Year Change | 58.94% | ||
3-Year Change | 770.63% | ||
5-Year Change | 272.03% | ||
Fundamentals | |||
Shares Outstanding | 65.3M | ||
Total Assets | $1.1B | ||
Market Cap | $8.8B | ||
Enterprise Value | $8.3B | ||
Period: QTR TTM FY | |||
Revenue | $274.4M | ||
Net Income | $220.0M | ||
Free Cash Flow | -$23.5M | ||
EBIT | $226.6M | ||
EBITDA | $227.0M | ||
Net Working Capital | $1.0B | ||
EPS | $3.07 | ||
Enterprise Value/EBITDA | 37 | ||
Enterprise Value/Revenue | 30 | ||
P/B | 8 | ||
P/E | 44 | ||
PEG | 1 | ||
Price/Free Cash Flow | -375 | ||
Price/Operating Cash Flow | -379 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue